Inquiry Now
BCR-ABL1 Fusion Gene Screening Reagents [Fluorescent Probe based]
Introducing Our Cutting-Edge BCR-ABL1 Fusion Gene Screening Kit!
Unveiling the Future of Precision Diagnosis with Dual-Labeled TaqMan Probe and Real-Time PCR Platform. Are you ready to revolutionize your molecular diagnostics? Look no further than our state-of-the-art BCR-ABL1 Fusion Gene Screening Kit, powered by the latest advancements in dual-labeled TaqMan probe technology and real-time PCR platform.
Why Choose Our Kit?
- Unmatched Accuracy: Say goodbye to uncertainty! Our kit offers unparalleled precision in detecting BCR-ABL1 fusion genes, ensuring reliable results every time.
- Rapid Turnaround Time: Time is of the essence in diagnostics. With our efficient real-time PCR platform, you’ll get swift results, enabling prompt decision-making for patient care.
- Streamlined Workflow: Simplify your laboratory processes with our user-friendly kit. Designed for seamless integration into your workflow, it minimizes hands-on time and maximizes efficiency.
- Superior Sensitivity: Don’t miss a single mutation! Our kit’s sensitivity enables detection of even low-level BCR-ABL1 fusion genes, empowering you to catch abnormalities early on.
- Robust Performance: Trust in reliability! Our kit undergoes rigorous testing to ensure consistent and dependable performance, giving you confidence in your diagnostic outcomes.
- Comprehensive Support: From installation to interpretation, our dedicated support team is here for you every step of the way. Count on us for comprehensive assistance and training.
Unlock the Potential of Precision Medicine Today! With our BCR-ABL1 Fusion Gene Screening Kit, you’re not just diagnosing—you’re paving the way for personalized treatment strategies tailored to individual patients. Embrace the power of molecular precision and elevate your diagnostic capabilities with us.
Ready to embark on the future of diagnostics? Contact us now to learn more and revolutionize your laboratory practice!
- Quantitative
ORDER INFORMATION
| REF | PACKAGE |
|---|---|
| BCRABL1Q/WBB/25 | 25 reactions |
| BCRABL1Q/WBB/100 | 100 reactions |
| BCRABL1D/WBB/25 | 25 reactions |
| BCRABL1D/WBB/100 | 100 reactions |
| INTENDED USER | For research use only and NOT intended for in vitro diagnostics. |
| TECHNOLOGY | Real-Time PCR with hydrolysis probes |
| TARGET SEQUENCE | The breakpoint on chromosome 22 between exons 12 and 16 of the BCR gene (Mbcr) and the breakpoint on chromosome 9 between exons 1 and 2 of the ABL gene (P210) |
| ANALYTICAL SPECIFICITY | 100 % |
| ANALYTICAL SENSITIVITY (LoD with probability 95 %) | 0.98 copies/µl using Wobble Base manual extraction Viral DNANucleic Acid Kit |
| DIAGNOSTIC SPECIFICITY | 100.00% |
| DIAGNOSTIC SENSITIVITY | ~1 tumor cell in 100,000 normal cells |
| LINEAR RANGE | 1.00E+09 to 1.00E+00 copies/µl |
| DYNAMIC RANGE | 1010 – LoD IU/ml (LoD varying according to the extraction and material used) |
| REPORTING UNITS | Normalized ratio of BCR/ABL1 (p210) to endogenous ABL1 mRNA with conversion to a percentage referenced to the international scale (IS) |
| CONVERSION FACTOR | 1.25 |
| Controls | Inhibition and extraction control, negative control, positive control |
| VALIDATED SPECIMAN | Whole blood (EDTA) |
| STORAGE | -20 ± 5 °C |
| DETECTION CHANNELS | FAM, HEX(VIC) |
| INSTRUMENTS | COMPATIBLE WITH A WIDE RANGE OF REAL-TIME PCR DEVICES |